Search

Ganesh A Prasanna

from Acton, MA
Age ~55

Ganesh Prasanna Phones & Addresses

  • 13 Wood Ln, Acton, MA 01720 (978) 266-0130
  • 2200 Taxco Rd, Fort Worth, TX 76116 (817) 731-8759
  • 3445 Riverstone Cir, Fort Worth, TX 76116 (817) 731-8759
  • 7321 Moon Ridge Ct, Fort Worth, TX 76133 (817) 423-1011
  • Benbrook, TX
  • 12277 Middlebrook Sq, San Diego, CA 92128 (858) 451-3229
  • 9878 Mercy Rd, San Diego, CA 92129 (858) 547-9319
  • Detroit, MI
  • 7321 Moon Ridge Ct, Fort Worth, TX 76133 (817) 832-0903

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ganesh Prasanna
Treasurer
ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS
Membership Organization
PO Box 2010, Mansfield, TX 76063
6201 S Fwy, Fort Worth, TX 76134
6900 Holw Oak Trl, Midlothian, TX 76063

Publications

Us Patents

Nitric Oxide Donating Prostamides

View page
US Patent:
8101658, Jan 24, 2012
Filed:
May 11, 2009
Appl. No.:
12/991855
Inventors:
Francesca Benedini - San Donato Milanese, IT
Stefano Biondi - Pero, IT
Valerio Chiroli - Milan, IT
Wesley Kwan Mung Chong - Encinitas CA, US
Liming Dong - San Diego CA, US
Achim Hans-Peter Krauss - San Marcos CA, US
Fabio Nicoli - Milan, IT
Ganesh Prasanna - San Diego CA, US
William Francois Vernier - San Diego CA, US
Yi Yang - San Diego CA, US
Assignee:
Nicox S.A. - Sophia Antipolis-Valbonne
International Classification:
A61K 31/04
A61K 31/16
C07C 203/04
C07C 291/00
US Classification:
514509, 558482
Abstract:
Nitroderivatives of prostaglandins having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.

Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma

View page
US Patent:
8252793, Aug 28, 2012
Filed:
Aug 17, 2011
Appl. No.:
13/211827
Inventors:
Keith D. Combrink - Arlington TX, US
Suchismita Mohapatra - Arlington TX, US
Mark R. Hellberg - Arlington TX, US
Najam A. Sharif - Arlington TX, US
Ganesh Prasanna - Fort Worth TX, US
Iok-Hou Pang - Grand Prairie TX, US
Bryon Severns - Arlington TX, US
Hwang-Hsing Chen - Fort Worth TX, US
Abdelmoula Namil - Arlington TX, US
Assignee:
Alcon Research, Ltd. - Fort Worth TX
Astellas Pharma Inc. - Tokyo
International Classification:
A61K 31/5377
A61K 31/444
A61K 31/496
A61K 31/4545
A61K 31/506
A61K 31/4439
C07D 401/14
C07D 498/04
C07D 413/14
C07D 401/06
A61P 9/12
A61P 27/06
US Classification:
5142345, 514338, 514333, 514302, 51425309, 514318, 514275, 546116, 546194, 5462737, 546256, 544364, 544331, 544131
Abstract:
The invention provides compositions and methods for treating and/or preventing ocular disorders associated with increased intraocular pressure. In particular, the compounds are bradykinin agonists.

Endothelin Antagonists And Endothelin-Converting Enzyme Inhibitors For The Treatment Of Glaucoma

View page
US Patent:
20030176356, Sep 18, 2003
Filed:
Apr 24, 2002
Appl. No.:
10/131787
Inventors:
Thomas Yorio - Burleson TX, US
Ganesh Prasanna - Fort Worth TX, US
Adnan Dibas - Fort Worth TX, US
Martha Stokely - Fort Worth TX, US
Assignee:
University of North Texas Health Science Center - Fort Worth TX
International Classification:
A61K038/08
A61K031/519
US Classification:
514/017000, 514/259100
Abstract:
A pharmaceutical composition, containing a therapeutically effective amount of an endothelin (“ET”) antagonists and/or an endothelin-converting enzyme (“ECE”) inhibitors and a pharmaceutically acceptable carrier. The pharmaceutical composition is useful for treating normal-tension and primary open-angle glaucoma and prevents optic nerve damage and retinal ganglion cell death associated with these ocular diseases.

Phenanthroline And Derivatives Thereof Used To Lower Intraocular Pressure In An Affected Eye

View page
US Patent:
20060111388, May 25, 2006
Filed:
Nov 18, 2005
Appl. No.:
11/282277
Inventors:
Adnan Dibas - Arlington TX, US
Thomas Yorio - Burleson TX, US
Ganesh Prasanna - San Diego CA, US
Assignee:
University of North Texas Health Science Center at Fort Worth - Fort Worth TX
International Classification:
A61K 31/4745
A61K 31/5377
A61K 31/557
A61K 31/4178
A61K 31/137
US Classification:
514292000, 514232500, 514573000, 514397000, 514649000
Abstract:
Methods and compositions used for lowering intraocular pressure. More particularly, the methods and compositions for lowering intraocular pressure pertain to the use of at least a phenanthroline derivative in an ophthalmic delivery solution.

Ep2 Agonists

View page
US Patent:
20080045545, Feb 21, 2008
Filed:
Jul 27, 2007
Appl. No.:
11/829176
Inventors:
Ganesh Prasanna - San Diego CA, US
Charles Bosworth - Oceanside CA, US
Jennifer Lafontaine - San Diego CA, US
International Classification:
A61K 31/505
A61K 31/38
A61K 31/41
A61P 27/06
C07D 277/00
C07D 401/00
C07D 333/22
C07D 213/00
A61K 31/426
A61K 31/4375
US Classification:
514256000, 514341000, 514357000, 514369000, 514445000, 544333000, 546275400, 546339000, 548186000, 549072000
Abstract:
The invention provides EP2 agonists, methods for their preparation, pharmaceutical compositions containing these compounds, and methods of using these compounds and compositions for lowering intraocular pressure and thereby treating glaucoma.

Ep2 Agonists

View page
US Patent:
20100105905, Apr 29, 2010
Filed:
Oct 7, 2009
Appl. No.:
12/575373
Inventors:
Ganesh Prasanna - Fort Worth TX, US
Charles Floyd Bosworth - Oceanside CA, US
Jennifer Anne Lafontaine - San Diego CA, US
International Classification:
C07D 401/12
C07D 277/56
C07D 409/12
C07D 333/38
C07D 317/46
C07C 311/02
C07D 417/12
US Classification:
544333, 544405, 5462754, 548201, 5483657, 549 71, 549443, 564 95
Abstract:
The invention provides EP2 agonists, methods for their preparation, pharmaceutical compositions containing these compounds, and methods of using these compounds and compositions for lowering intraocular pressure and thereby treating glaucoma.

Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma

View page
US Patent:
20120283260, Nov 8, 2012
Filed:
Jul 24, 2012
Appl. No.:
13/556670
Inventors:
Keith D. Combrink - Arlington TX, US
Suchismita Mohapatra - Arlington TX, US
Mark R. Hellberg - Arlington TX, US
Najam A. Sharif - Arlington TX, US
Ganesh Prasanna - Fort Worth TX, US
Iok-Hou Pang - Grand Prairie TX, US
Bryon Severns - Arlington TX, US
Hwang-Hsing Chen - Fort Worth TX, US
Abdelmoula Namil - Arlington TX, US
Assignee:
ASTELLAS PHARMA INC. - Chuo-ku Tokyo
ALCON RESEARCH, LTD. - Fort Worth TX
International Classification:
A61K 31/4439
C07D 401/14
A61K 31/444
C07D 498/04
A61K 31/496
A61K 31/4545
A61K 31/506
C07D 413/14
A61K 31/5377
C07D 471/04
C07D 401/12
A61K 31/4709
C07D 403/04
A61K 31/4184
A61P 27/02
A61P 27/06
A61P 9/12
C07D 401/06
US Classification:
5142345, 5462737, 514338, 546256, 514333, 546116, 514302, 544364, 51425309, 546194, 514318, 544331, 514275, 544131, 546121, 514300, 544362, 51425304, 546153, 514312, 544333, 514256, 546162, 514313, 5483061, 514395
Abstract:
The invention provides compositions and methods for treating and/or preventing ocular disorders associated with increased intraocular pressure. In particular, the compounds are bradykinin agonists.

Indane And Indoline Derivatives And The Use Thereof As Soluble Guanylate Cyclase Activators

View page
US Patent:
20170197940, Jul 13, 2017
Filed:
Jul 2, 2015
Appl. No.:
15/320810
Inventors:
Christopher M. ADAMS - Arlington MA, US
Doug BEVAN - Chelmsford MA, US
Michael Paul CAPPARELLI - Cambridge MA, US
Takeru EHARA - Arlington MA, US
Luciana FERRARA - Stoughton MA, US
Nan JI - Arlington MA, US
Mitsunori KATO - Cambridge MA, US
Nello MAINOLFI - Belmont MA, US
Erik MEREDITH - Hudson MA, US
Muneto MOGI - Waltham MA, US
James J. POWERS - Waltham MA, US
Ganesh PRASANNA - Acton MA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
C07D 401/14
C07D 401/12
A61K 31/454
C07D 413/14
A61K 31/4725
A61K 31/4439
C07D 405/14
A61K 9/00
A61K 31/4545
Abstract:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Ganesh A Prasanna from Acton, MA, age ~55 Get Report